Development and Evaluation of a Web-Based Paediatric Drug Information System for Germany
<b>Background:</b> Off-label use is frequent in paediatrics but that does not necessarily mean that the risk-benefit ratio is negative. Nevertheless, evidence-based data is essential for safe drug therapy. In Germany, there is no publicly available compendium providing transparent, evide...
Main Authors: | Julia Zahn, Stefan Wimmer, Wolfgang Rödle, Irmgard Toni, Brita Sedlmayr, Hans-Ulrich Prokosch, Wolfgang Rascher, Antje Neubert |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | https://www.mdpi.com/2226-4787/9/1/8 |
Similar Items
-
Manipulation of Medicinal Products for Oral Administration to Paediatric Patients at a German University Hospital: An Observational Study
by: Julia Zahn, et al.
Published: (2020-06-01) -
Drug Utilisation and Off-Label Use on a German Neonatal Intensive Care Unit: A Retrospective Cohort Study and 10-Year Comparison
by: Carmen Geißler, et al.
Published: (2020-09-01) -
Effects of the Off-Label Drug Prescription in the Paediatric Population in Spain from the Adoption of the Latest European Regulation: A Pre-Post Study
by: Irene Lizano-Díez, et al.
Published: (2021-04-01) -
Paediatric Medicines in Europe: The Paediatric Regulation—Is It Time for Reform?
by: Maddalena Toma, et al.
Published: (2021-02-01) -
Children in clinical trials: survey on the current situation in paediatric university clinics in Germany
by: Hundt, Ferdinand, et al.
Published: (2008-03-01)